Clinical trial
MGA031, Sirolimus and Tacrolimus in Islet Transplantation
NCT00265473 · University of Minnesota, Other · Completed
Key facts
| NCT number | NCT00265473 |
|---|---|
| Title | MGA031, Sirolimus and Tacrolimus in Islet Transplantation |
| Official title | hOKT3γ1 (Ala-Ala), Sirolimus and Low Dose Tacrolimus Therapy in Type 1 Diabetic Islet Allograft Recipients |
| Lead sponsor | University of Minnesota, Other |
| Collaborators | National Institutes of Health (NIH) NIH Juvenile Diabetes Research Foundation |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Type 1 Diabetes Mellitus, Hypoglycemia |
| Intervention type | Biological |
| Interventions | Allogeneic Islets of Langerhans |
| Enrollment | 5 |
| Start date | Nov 1, 2005 |
| Primary completion | May 1, 2010 |
| Completion | Jun 1, 2010 |
| First posted | Dec 14, 2005 |
| Last update posted | Mar 9, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: